2017
DOI: 10.4103/ijccm.ijccm_72_17
|View full text |Cite
|
Sign up to set email alerts
|

Thromboelastography for evaluation of coagulopathy in nonbleeding patients with sepsis at intensive care unit admission

Abstract: Background:Thromboelastography (TEG) is a global test of coagulation which analyzes the whole coagulation process. TEG is popular in trauma, liver transplant, and cardiac surgeries, but studies in sepsis are limited. We have assessed the utility of TEG for evaluating coagulopathy in nonbleeding patients with sepsis.Materials and Methods:A prospective, observational study was done in 12-bedded Intensive Care Unit (ICU) of a tertiary care hospital in North India, during May 2014-November 2014. After ethical clea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
9
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 24 publications
1
9
0
1
Order By: Relevance
“…Hypercoagulability was observed in the early stage of sepsis, consistent with the aforementioned hypothesis of "immunothrombosis" defense (1,3,15). The development of hypocoagulability is commonly associated with the increasing severity of each stage (severe sepsis and septic shock) (12,15,16,27). Previous studies observed hemostatic response by a rapid increase in clot mass development (with higher α and MCF), possibly indicating a hypercoagulable phase and potential thromboembolic risk in the early stage of sepsis followed by the progression of hypocoagulable trends (with prolonged CT and CFT) in the later phase (6,28).…”
Section: Discussionsupporting
confidence: 73%
“…Hypercoagulability was observed in the early stage of sepsis, consistent with the aforementioned hypothesis of "immunothrombosis" defense (1,3,15). The development of hypocoagulability is commonly associated with the increasing severity of each stage (severe sepsis and septic shock) (12,15,16,27). Previous studies observed hemostatic response by a rapid increase in clot mass development (with higher α and MCF), possibly indicating a hypercoagulable phase and potential thromboembolic risk in the early stage of sepsis followed by the progression of hypocoagulable trends (with prolonged CT and CFT) in the later phase (6,28).…”
Section: Discussionsupporting
confidence: 73%
“… 6 , 22 Thromboelastography can be an easy and helpful test to learn about this new disease and may have potential in deciding appropriate anticoagulant doses and duration. 7 , 23 , 24 Some experts advise TEG in patients with severe COVID-19 for monitoring coagulation and adjusting the heparin dosage. 25 More studies are needed to evaluate the applicability of TEG in understanding the disease, identifying appropriate doses and duration of thromboprophylaxis, and predicting outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, this goal-directed management which has been since several years incorporated as a Grade 1C recommendation in the latest edition of the European guideline on management of major bleeding and coagulopathy following trauma should be more frequently considered to be used as goal-directed therapy. [224]…”
Section: Resultsmentioning
confidence: 99%
“…TEG is not an alternative to the conventional laboratorial coagulation tests such as INR and aPTT; however, it adds more information to guide blood transfusions such as clot strength and fibrinolysis and to differentiate between normocoagulant, hypocoagulant, and hypercoagulant states in septic patients. [12] However, a recent systematic review demonstrates that the evidence to show the accuracy of TEG and ROTEM in trauma still needs further evaluation and more research involvement with prospective, randomized controlled trials. [34]…”
Section: Introductionmentioning
confidence: 99%